Pegylated IFN-α2a combined to imatinib mesylate 600 mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600 mg daily alone
| Autor: | Nicolini, Franck E., Hayette, Sandrine, Legros, Laurence, Rousselot, Philippe, Maloisel, Frédéric, Tulliez, Michel, Guerci, Agnès, Charbonnier, Aude, Prébet, Thomas, Rigal-Huguet, Françoise, Chabane, Kaddour, Magaud, Jean-Pierre, Paillet, Carole, Pivot, Christine, Michallet, Mauricette |
|---|---|
| Zdroj: | In Leukemia Research 2011 35(1):80-86 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect